Korea Research Institute of Chemical Technology;Handok Pharmaceuticals Co., Ltd.
发明人:
申请号：
EP13781273.1
公开号：
EP2842938A1
申请日:
2013.04.25
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a beta-alanine derivative, pharmaceutically acceptable salts thereof, and a pharmaceutical composition including the same as an active ingredient. The novel beta-alanine derivative and pharmaceutically acceptable salts thereof according to the present invention may effectively inhibit the activity of DGAT1, which is an enzyme serving as a catalyst in the final step of the synthesis of neutral lipids, to thereby be effectively used as a pharmaceutical composition for preventing or treating various lipid metabolism-related disorders selected from the group consisting of obesity, dyslipidemia, fatty liver, insulin resistance syndrome, and hepatitis.
